QUBIS Ltd.

About The Fund

QUBIS Ltd is a venture capital fund operating as an investment arm of Queen's University Belfast in the United Kingdom. They specialize in transforming high-quality academic research into profitable and impactful commercial entities. Through close collaboration with skilled academics, entrepreneurs, investors, and industry experts, they work to establish successful spin-off companies that fuse advanced research and development with solutions and services aimed at the market. They focus on investing in a wide range of industries, which include Software, IT and TMT (Technology, Media, Telecom), Biotech, Hardware and Manufacturing, Medical Devices and Hospital Services, Real Estate and Construction, Life Sciences, and Mobile technologies. With an expertise in equity investments, QUBIS Ltd supports ventures at various stages, mainly seed, startup, and early stage. Their primary objective is to facilitate the journey from research to wealth creation by leveraging the dynamic environment and innovation developed within Queen's University. Over time, QUBIS has witnessed significant achievements with its portfolio companies, such as notable IPOs and acquisitions. Examples of these success stories include Fusion's growth in trading value, Kainos's successful launch on the London Stock Exchange, PathXL's acquisition by Philips, Andor Technology's negotiation of a substantial acquisition deal, Trucorp's attraction of private equity investment, Amphion's purchase for a major digital signal processing IP, and Avalon Instruments' acquisition by PerkinElmer. With more than 90 companies and 2700 employees stemming from their investments, QUBIS has raised over 100 million in total capital. They are committed to ongoing support, providing services like the QUBIS Innovation Fund (SEIS) and celebrating over 40 years of driving innovation and impacting the global market.